Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
LyondellBasell $500 million inaugural green bond offering
The investment-grade notes are due 2033
Toyota Motor Credit $2 billion notes offering
We advised the company on the SEC-registered notes offering
Emergent BioSolutions $150 million at-the-market offering
The shares are listed on the NYSE
Texas Instruments $1.6 billion notes offering
We advised Texas Instruments on its investment-grade debt offering
Forbion European Acquisition combination with enGene
We are advising Forbion European Acquisition on its de-SPAC transaction
Monitronics International chapter 11 filing and DIP financing
We are advising the ad hoc lender group that is backstopping the restructuring
Honeywell €1.15 billion senior notes offering
The investment-grade notes are due 2027 and 2032
Honeywell $1.75 billion senior notes offering
The investment-grade notes are due 2029 and 2034
Merck $6 billion notes offering
The investment-grade notes offering consists of six tranches
Weyerhaeuser $750 million notes offering
The investment-grade notes are due 2026